---
title: "ATTENTION West Pharmaceutical Services, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/237832165.md"
description: "Levi & Korsinsky has launched an investigation into West Pharmaceutical Services, Inc. for potential violations of federal securities laws. Following the company's disappointing full-year 2025 guidance, which fell short of analysts' expectations despite positive 4Q 2024 results, WST's stock plummeted by approximately 38%, closing at $199.11 per share. Investors affected by this situation are encouraged to contact Levi & Korsinsky for further assistance."
datetime: "2025-04-28T11:25:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237832165.md)
  - [en](https://longbridge.com/en/news/237832165.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237832165.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/237832165.md) | [English](https://longbridge.com/en/news/237832165.md)


# ATTENTION West Pharmaceutical Services, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights

**NEW YORK, NY / ACCESS Newswire / April 28, 2025 /** Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") concerning possible violations of federal securities laws.

On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations. Management attributed the low guidance to currency headwinds, operating expenses and "glucose monitoring transition." Analysts expressed shock and disappointment at the Company's full year 2025 outlook.

Following this news, WST's stock price fell by $123.17 per share, or approximately 38% to close at $199.11 per share. To obtain additional information, go to:

https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=145701&wire=1

or contact Joseph E. Levi, Esq.

**WHY LEVI & KORSINSKY:** Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.

**CONTACT:**

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

Ed Korsinsky, Esq.

**SOURCE:** Levi & Korsinsky, LLP

View the original press release on ACCESS Newswire

### 相關股票

- [West Pharmaceutical (WST.US)](https://longbridge.com/zh-HK/quote/WST.US.md)

## 相關資訊與研究

- [Bamco Inc. NY Sells 108,501 Shares of West Pharmaceutical Services, Inc. $WST](https://longbridge.com/zh-HK/news/269593309.md)
- [West Pharmaceutical Services, Inc. $WST Shares Sold by Pitcairn Co.](https://longbridge.com/zh-HK/news/269708563.md)
- [Jump Financial LLC Invests $4.43 Million in West Pharmaceutical Services, Inc. $WST](https://longbridge.com/zh-HK/news/269220909.md)
- [Stevens Capital Management LP Acquires Shares of 1,232 West Pharmaceutical Services, Inc. $WST](https://longbridge.com/zh-HK/news/267183617.md)
- [West Pharmaceutical Services Keeps Quarterly Dividend at $0.22 a Share, Payable Feb. 4 to Shareholders of Record on Jan. 28](https://longbridge.com/zh-HK/news/269228011.md)